Neurology® Podcast

New Treatment for IDH mt Gliomas

07.20.2023 - By American Academy of NeurologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in The New England Journal of Medicine. Visit NPUb.org/Podcast for associated article links.

More episodes from Neurology® Podcast